South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "GLOMTHERA" on Aug. 1. The details about the trademark application no. UK00004243104 published in the journal no. 2025/035 (Aug. 29).
With Stratagem Intellectual Property Management Limited as representative, Purespring Therapeutics Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical, medical and veterinary preparations and substances for the prevention, diagnosis and treatment of kidney diseases; reagents for use in medical genetic testing; biological, chemical and biochemical reagents for medical use; gene therapy products for medical and veterinary use; medical and veterinary preparations containing therapeutic DNA and RNA; pharmaceutical research tools in the nature of biological, chemical and biochemical reagents; pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, including, gene therapies, viral vectors, and nucleic-acid delivery products for use in the treatment of kidney diseases and disorders; pharmaceutical preparations for use in gene therapy; viral vectors for use in the delivery of gene therapy; adeno-associated virus (AAV) gene therapy; drug delivery agents consisting of capsids that facilitate delivery of pharmaceuticals and biopharmaceuticals; vaccines. .
Class 42 : Pharmaceutical, medical and scientific research; scientific information; research in the field of gene therapy; services for assessing the efficiency of pharmaceutical and medical preparations and substances; clinical trials; pharmaceutical and biopharmaceutical drug development services; research, and development of pharmaceutical preparations for gene therapy; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development regarding the use of screening platforms to discover, research and develop novel capsids for genetic delivery of gene therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery; providing medical and scientific research information on the prevention, diagnosis, and treatment of kidney diseases; providing a website featuring medical information and medical research; platform as a service (PAAS) featuring computer software platforms in the field of drug discovery and drug development. .
Class 44 : Pharmaceutical and medical services; diagnostic and screening services; health care services; advisory services in the fields of medicine and pharmacology; consultancy and information services relating to pharmaceutical and medical preparations and substances; medical diagnosis and treatment of kidneydiseases; medical testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of kidney diseases; pharmaceutical and medical information.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004243104
Disclaimer: Curated by HT Syndication.
